Within the central nervous system, APOE4 is produced by a variety of cell types under different conditions, posing a challenge for studying its roles in AD pathogenesis [54]. The evidence supporting APOE4 as an AD risk factor is that APOE4 increases the risk of both early- and late-onset AD [55–57]. The gene discussed is APOE; the disease is Alzheimer disease.